Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
McKesson
UBS
Baxter
Cerilliant
Accenture
Merck
AstraZeneca

Generated: January 22, 2019

DrugPatentWatch Database Preview

Valeant Pharm Intl Company Profile

« Back to Dashboard

What is the competitive landscape for VALEANT PHARM INTL, and what generic and branded alternatives to VALEANT PHARM INTL drugs are available?

VALEANT PHARM INTL has forty-four approved drugs.



Summary for Valeant Pharm Intl
US Patents:0
Tradenames:37
Ingredients:32
NDAs:44

Drugs and US Patents for Valeant Pharm Intl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl RESERPINE reserpine TABLET;ORAL 009667-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl ELDECORT hydrocortisone CREAM;TOPICAL 084055-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 085896-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl EFUDEX fluorouracil SOLUTION;TOPICAL 016831-002 Approved Prior to Jan 1, 1982 AT RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Valeant Pharm Intl

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-003 Dec 30, 1988 4,797,405 ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-001 Dec 30, 1988 4,166,182 ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-002 Dec 30, 1988 4,166,182 ➤ Sign Up
Valeant Pharm Intl ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 5,648,093 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for VALEANT PHARM INTL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Inhalation Solution 6 gm/vial ➤ Subscribe 2014-05-22
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cerilliant
Fish and Richardson
Johnson and Johnson
US Department of Justice
Harvard Business School
Daiichi Sankyo
Cipla
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.